Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

This study has been completed.
Kansas City Area Life Sciences Institute, Inc.
Information provided by (Responsible Party):
Nancy Hammond, MD, University of Kansas Medical Center Research Institute Identifier:
First received: June 21, 2007
Last updated: January 17, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)